A Multicenter, Retrospective Study (RE-ENACT 2) on RazumabTM (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion
Figures are generally photos, graphs and static images that would be represented in traditional pdf publications.
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020